Results
1 -
10 of
17
(Click
here to explore results)
- New Therapeutic Strategies for Type 2 Diabetes: Small Molecule Approaches, Chapter 3 SGLT2 Inhibitors in Development. William N. Washburn
, 2012
, Pages 29-87
- Nuclear Magnetic Resonance: Volume 47, NMR in living systems. Malcolm J. W. Prior
, 2022
, Volume 47
, Pages 240-284
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 6 New Drug Design and Therapeutic Development for Weight Reduction: Preclinical Studies and Clinical Trials. Steven P. Vickers, Helen C. Jackson, Sharon C. Cheetham
, 2015
, Pages 90-116
- Nanotechnology for Diabetes Management, Chapter 3 Optimizing the Current Type 2 Diabetes Antidiabetics with Nanotechnologies: Where Do We Stand?. Amar Abderrahmani, Sabine Szunerits, Stephane Dalle, Rabah Boukherroub
, 2023
, Pages 92-112
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 14 Drug Design and Therapeutic Development for Diabetes Mellitus. Shahrad Taheri, Hadeel Zaghlool, Maria Pallayova
, 2015
, Pages 297-336
- Natural Product Chemistry for Drug Discovery, Chapter 11 A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008. Mark S. Butler
, 2009
, Pages 321-354
- New Therapeutic Strategies for Type 2 Diabetes: Small Molecule Approaches, Subject Index
, 2012
, Pages 501-515
- Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 1 The Discovery of the Dipeptidyl Peptidase-4 (DPP4) Inhibitor Onglyza™: From Concept to Market. Jeffrey A. Robl, Lawrence G. Hamann
, 2011
, Pages 1-24
- Electrochemistry: Volume 16, 2D materials for sensing applications. Prashanth Shivappa Adarakatti, Samrat Devaramani
, 2022
, Volume 16
, Pages 44-83
- Human-based Systems for Translational Research, Chapter 11 Human Microdosing/Phase 0 Studies to Accelerate Drug Development. R. Colin Garner
, 2015
, Pages 241-266